Paper74727
Pseudomembranous colitis: Presence of clostridial toxin.
Larson HE and 1 other. Lancet, 1977. Cited by 216 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pseudomembranous colitis: Presence of clostridial toxin. Papers, record 74727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/74727
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Toxins | Major topic |
| Clostridium | Major topic |
| Enterocolitis, Pseudomembranous | Major topic |
| Feces | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Antitoxins | |
| Biological Assay | |
| Culture Techniques | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 216 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,421,181 | Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38421181 | PubMed |
| 37,717,961 | Clostridioides (Clostridium) difficile: A silent nosocomial pathogen. | Saudi Med J | 2023 | https://conductscience.org/library/papers/37717961 | PubMed |
| 35,392,442 | Outcomes of Continuous Enteral Vancomycin Infusion in Intensive Care Unit Patients: A Novel Treatment Modality for Severe Clostridium Difficile Colitis. | Cureus | 2022 | https://conductscience.org/library/papers/35392442 | PubMed |
| 26,404,991 | Dentists, antibiotics and Clostridium difficile-associated disease. | Br Dent J | 2015 | https://conductscience.org/library/papers/26404991 | PubMed |
| 25,279,431 | Synthetic polymers active against Clostridium difficile vegetative cell growth and spore outgrowth. | J Am Chem Soc | 2014 | https://conductscience.org/library/papers/25279431 | PubMed |
| 24,296,572 | Variations in virulence and molecular biology among emerging strains of Clostridium difficile. | Microbiol Mol Biol Rev | 2013 | https://conductscience.org/library/papers/24296572 | PubMed |
| 24,064,435 | Epidemiology of Clostridium difficile infection. | J Pharm Pract | 2013 | https://conductscience.org/library/papers/24064435 | PubMed |
| 23,727,391 | A clinical and epidemiological review of non-toxigenic Clostridium difficile. | Anaerobe | 2013 | https://conductscience.org/library/papers/23727391 | PubMed |
| 18,475,679 | Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility. | Mediators Inflamm | 1995 | https://conductscience.org/library/papers/18475679 | PubMed |
| 16,352,825 | Isolation of RNA polymerase from Clostridium difficile and characterization of glutamate dehydrogenase and rRNA gene promoters in vitro and in vivo. | J Bacteriol | 2006 | https://conductscience.org/library/papers/16352825 | PubMed |
| 10,678,912 | New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization. | Infect Immun | 2000 | https://conductscience.org/library/papers/10678912 | PubMed |
| 8,358,706 | Clostridium difficile: clinical disease and diagnosis. | Clin Microbiol Rev | 1993 | https://conductscience.org/library/papers/8358706 | PubMed |
| 7,805,686 | Evaluation of an oligonucleotide probe and an immunological test for direct detection of toxigenic Clostridium difficile in stool samples. | Eur J Clin Microbiol Infect Dis | 1994 | https://conductscience.org/library/papers/7805686 | PubMed |
| 7,430,354 | Antimicrobial susceptibilities of Clostridium difficile. | J Clin Pathol | 1980 | https://conductscience.org/library/papers/7430354 | PubMed |
| 7,399,686 | Production of Clostridium difficile antitoxin. | Infect Immun | 1980 | https://conductscience.org/library/papers/7399686 | PubMed |
| 7,380,535 | Cecal toxin(s) from guinea pigs with clindamycin-associated colitis, neutralized by Clostridium sordellii antitoxin. | Infect Immun | 1980 | https://conductscience.org/library/papers/7380535 | PubMed |
| 7,333,662 | Comparison of two toxins produced by Clostridium difficile. | Infect Immun | 1981 | https://conductscience.org/library/papers/7333662 | PubMed |
| 7,254,132 | Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis. | Med Microbiol Immunol | 1981 | https://conductscience.org/library/papers/7254132 | PubMed |
| 7,240,430 | Antitoxin production in antibiotic-associated colitis? | J Clin Pathol | 1981 | https://conductscience.org/library/papers/7240430 | PubMed |
| 7,233,892 | Antimicrobial agent-associated colitis and diarrhea. | West J Med | 1980 | https://conductscience.org/library/papers/7233892 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/74727
GET https://conductscience.org/api/papers/v1/74727/cited_by?page=2